2018
DOI: 10.1111/jdv.15239
|View full text |Cite
|
Sign up to set email alerts
|

Decreased photosensitivity to UVA on vemurafenib combined with cobimetinib

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…Systemic drug photosensitivity presents mainly as exaggerated sunburn or acute eczema on sun-exposed areas, but also as urticaria, lichenoid reactions, melanoma induces immediate burning upon sun-exposure followed by well-limited painful edema and erythema that persist for a few days occurs in 22-66% of patients 8,36 , but this reaction is less frequent when vemurafenib is associated with a MEK inhibitor 37 . A similar pattern has also been described with other BRAF inhibitors and other targeted therapies for cancer, namely the anaplastic lymphoma kinase (ALK) inhibitor brigatinib (Fig.…”
Section: Clinical Presentations Of Drug Photosensitivitymentioning
confidence: 99%
“…Systemic drug photosensitivity presents mainly as exaggerated sunburn or acute eczema on sun-exposed areas, but also as urticaria, lichenoid reactions, melanoma induces immediate burning upon sun-exposure followed by well-limited painful edema and erythema that persist for a few days occurs in 22-66% of patients 8,36 , but this reaction is less frequent when vemurafenib is associated with a MEK inhibitor 37 . A similar pattern has also been described with other BRAF inhibitors and other targeted therapies for cancer, namely the anaplastic lymphoma kinase (ALK) inhibitor brigatinib (Fig.…”
Section: Clinical Presentations Of Drug Photosensitivitymentioning
confidence: 99%